THERAPEUTIC TRIAL OF IMURAN (AZATHIOPRINE) IN MULTIPLE SCLEROSIS

Abstract

A prospective, controlled trial of the therapeutic effect of azathioprine in 30 patients with multiple sclerosis was carried out. No significant advantage of azathioprine over placebo was demonstrated in non-re-sponders to corticosteroids or corticotrophin (p < 0.5). At the present time, it cannot be concluded from the trial whether or not azathioprine should be given to corticosteroid-responsive patients.